Prafull Raheja, MD
Interventional Cardiology · Louisville, KYNPI 1679732051
Payments from drug & device makers
Across 584 payments — averaging $45.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- Abbott$2K
- Edwards Lifesciences$2K
- Novartis$1K
- Terumo Medical Corporation$1K
- Johnson & Johnson$1K
- plus $6K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 66 | $13,052 |
| Abbott | 70 | $2,405 |
| Edwards Lifesciences | 10 | $1,599 |
| Novartis | 71 | $1,243 |
| Terumo Medical Corporation | 27 | $1,212 |
| Johnson & Johnson | 63 | $1,186 |
| Boston Scientific | 37 | $973 |
| AstraZeneca | 44 | $734 |
| Pfizer | 34 | $631 |
| Chiesi USA, Inc. | 19 | $565 |
| Cardiovascular Systems Inc. | 31 | $510 |
| Amgen | 16 | $299 |
| Abiomed | 5 | $276 |
| Merck | 14 | $242 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $233 |
| E.r. Squibb & Sons, L.L.C. | 10 | $169 |
| EKOS Corporation | 2 | $124 |
| Philips North America LLC | 8 | $119 |
| Cvrx, Inc. | 4 | $113 |
| Medicure Pharma Inc. | 1 | $101 |
| Lexicon Pharmaceuticals, Inc. | 4 | $85 |
| Bayer | 4 | $83 |
| Alnylam Pharmaceuticals Inc. | 4 | $76 |
| Scpharmaceuticals Inc. | 3 | $60 |
| Actelion Pharmaceuticals US, Inc. | 2 | $59 |
| Teleflex LLC | 4 | $56 |
| Boehringer Ingelheim | 3 | $52 |
| ZOLL Circulation Inc | 2 | $50 |
| Vital Connect, Inc | 1 | $42 |
| Kestra Medical Technology Services, Inc. | 1 | $39 |
| GSK | 2 | $39 |
| Novo Nordisk | 2 | $31 |
| Silk Road Medical, Inc. | 1 | $24 |
| Heartflow, Inc. | 1 | $22 |
| Inari Medical, Inc. | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Livanova USA, Inc. | 1 | $18 |
| Thrombolex, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
How this compares
$26,593 in reported general payments places this provider in the 70th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Louisville
- Thomas TuLouisville$1.4M
- Naresh SolankhiLouisville$545K
- Sreedevi GondiLouisville$535K
- Daniel StewartLouisville$290K
- Daniel RothschildLouisville$203K
- Ravi SharmaLouisville$109K
- Christopher SemderLouisville$103K
- Abdullahi OseniLouisville$97K
- Michael FlahertyLouisville$87K
- Sadip PantLouisville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.